Andean Precious Metals (CVE:APM – Free Report) had its target price cut by Desjardins from C$2.10 to C$2.00 in a research report released on Thursday morning,BayStreet.CA reports. They currently have a buy rating on the stock.
Andean Precious Metals Stock Up 7.5 %
Shares of CVE APM opened at C$1.29 on Thursday. The firm’s fifty day moving average is C$1.29 and its 200 day moving average is C$1.36. Andean Precious Metals has a 52 week low of C$0.57 and a 52 week high of C$2.18. The company has a market cap of C$135.47 million, a price-to-earnings ratio of 2.55 and a beta of 1.22.
Insider Activity
In other Andean Precious Metals news, Senior Officer Juan Carlos Sandoval Amare bought 31,300 shares of Andean Precious Metals stock in a transaction dated Friday, January 3rd. The shares were purchased at an average cost of C$1.21 per share, with a total value of C$37,860.48. Insiders own 69.37% of the company’s stock.
About Andean Precious Metals
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
Featured Articles
- Five stocks we like better than Andean Precious Metals
- 3 Small Caps With Big Return Potential
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Are Penny Stocks a Good Fit for Your Portfolio?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What is the FTSE 100 index?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.
